Trials / Completed
CompletedNCT01058044
Adherence to Oral Anticancer Treatment Using Electronic Monitoring System
A Pilot Study of Adherence to Oral Anticancer Treatment Using Electronic Monitoring System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Centre Jean Perrin · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe adherence to 3 oral anticancer treatment: i) a chemotherapeutic regimen with capecitabine (alone or in association with lapatinib), ii) or sunitinib an tyrosine kinase inhibitor, iii) or an non-steroidal aromatase inhibitor. Moreover, this study is aimed at evaluating the feasibility to use a " Medication Event Monitoring System " (MEMS®) in order to assess adherence of an oral anticancer treatment delivered by dispensary pharmacy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Evaluation of adherence to 3 oral anticancer treatment using a " Medication Event Monitoring System " | Evaluation of adherence using a " Medication Event Monitoring System " (MEMS®) for oral anticancer treatment delivered by dispensary pharmacy |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2011-01-01
- First posted
- 2010-01-28
- Last updated
- 2012-08-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01058044. Inclusion in this directory is not an endorsement.